Gheuens Sarah bought AGIO
October 30, 2025 · Form 4 insider transaction
Gheuens Sarah bought 200 shares of Agios Pharmaceuticals, Inc. at $25.01 per share, a transaction worth $5.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
200
Price
$25.01
Total value
$5.0K
InsiderGheuens Sarah
Role—
SecurityCommon stock
Transaction codeM: Option exercise
Transaction dateOctober 30, 2025
Filing dateNovember 3, 2025
Shares owned after61,927
OwnershipDirect
10b5-1 planNo
AmendedNo